Successful drugs, or successful drugs that are eligible for patent protection? I imagine[1] it would be much harder to turn a profit on the massive upfront costs if you immediately had to compete with the existing manufacturers at generic-scale prices.
It seems like it might be useful (assuming it isn't already) to separate the rights concerning drug discovery and those demonstrating efficacy/safety to allow costs to be recovered.
Then again, it needs to be weighed against the inevitable rent-seeking that pharma has a name for.
[1] but don't have any evidence handy to back it up, so ICBW.
It seems like it might be useful (assuming it isn't already) to separate the rights concerning drug discovery and those demonstrating efficacy/safety to allow costs to be recovered.
Then again, it needs to be weighed against the inevitable rent-seeking that pharma has a name for.
[1] but don't have any evidence handy to back it up, so ICBW.